XASE · AEON
+2.76% · +$0.0053 · Vol 956.9K
Market closed · last close 4:00 PM ET · price as of 20:00:00 ET
AEON Biopharma, Inc.

AEON Biopharma, Inc.

PHARMACEUTICAL PREPARATIONS
$0.1974
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
Earnings absence reason unknown
AEON
AEON Biopharma, Inc.
Mon Aug 24 · market closed · Markets closed · resumes Tue 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

59/ 100
Veridion Score
NEUTRAL · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Mon Aug 24 · market closed · Markets closed · resumes Tue 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is AEON moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading AEON catalysts
About AEON Biopharma, Inc.
PHARMACEUTICAL PREPARATIONS
Listed since
2023
Employees
8
Country
US

AEON Biopharma Inc is a biopharmaceutical company focused on the development of ABP-450 (prabotulinumtoxinA), a biosimilar to Botox (onabotulinumtoxinA), for therapeutic indications. The company is advancing ABP-450 through the biosimilar regulatory pathway and holds development and commercialization rights across multiple international markets.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.2010
Day high
$0.2018
Day low
$0.1899
Previous close
$0.1921
52W high
$1.40
-85.90% from high
52W low
$0.1899
1% of range
Market cap
$9.6M
EPS
$-1.3000
Beta
0.60
Shares out
49.9M
Volume
956.9K
0.30× rel vol
Avg volume
3.1M
VWAP
$0.1979
Price history computed in-house
1W
-19.43%
1M
-21.26%
3M
-73.68%
1Y
-72.77%
YTD
-82.05%
SMA 50 $0.4243 · below
SMA 200 $0.8407 · below
52W position 1%

AEON overview

Veridion Score
59
Registered · 2026-08-24
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around AEON.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading AEON Form 4 filings
Public disclosures

Congress activity in AEON

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for AEON in the cached public ledger.

Federal contracts

AEON contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for AEON in this window.
Lobbying spend

AEON lobbying filings, year to date.

Registered lobbying filings matched to AEON Biopharma, Inc..

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for AEON in this window.
Loading news for AEON
Analyst ratings
Sovereign unlock shows live analyst consensus for AEON.
Options
Sovereign unlock shows live options positioning for AEON.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.